Company to Pursue Technologies to Improve Muscle Strength, Bone Health, and Other Longevity Indicators
NEW YORK, July 24, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO)...
Wuppertal, Germany, July 24, 2025 - Aicuris Anti-infective Cures AG today announced the completion of patient enrollment in its pivotal Phase 3 trial, PRIOH-1, evaluating pritelivir for the treatment of refractory and/or treatment resistant herpes simplex virus (HSV) infections in immunocompromised patients. The company’s lead candidate is a small molecule specifically inhibiting the viral helicase-primase complex, which represents a novel mechanism of action distinct from current HSV therapies.
Partnership with DeliverHealth brings InstaNote (eSOne platform) to New Zealand clinicians
AUCKLAND, New Zealand, July 23, 2025 /PRNewswire/ -- iMedX is proud to announce its formal endorsement by Health New Zealand | Te...
SUNRISE, Fla., July 23, 2025 /PRNewswire/ -- North American Partners in Anesthesia (NAPA), the nation's largest single-specialty anesthesia services organization, has been awarded a...
Collaboration includes strategic investment by CharacterStrong’s parent company FullBloom to further scale K-12 mental health solutions that improve student outcomes
Collaboration includes strategic investment by CharacterStrong’s parent company FullBloom to further scale K-12 mental health solutions that improve student outcomes
Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients
Largest commercial insurer in the United States releases positive comprehensive coverage for AI-enabled Heartflow Plaque Analysis to support precise diagnosis and management of patients
FRANKLIN LAKES, N.J., July 22, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical...